Arecor Therapeutics plc announced that Susan Lowther has decided to step down from her role as Company Secretary and as a Board Director, to pursue new opportunities. A search for Susan's successor is underway and her last day with Arecor is expected to be on the 22 July, to ensure an effective handover.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
136.5 GBX | 0.00% | -0.73% | -25.21% |
09/05 | Arecor Therapeutics collaborates with Medtronic on novel insulin | AN |
09/05 | Arecor Therapeutics, Medtronic Team Up for Thermostable Insulin Development | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.21% | 52.32M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- AREC Stock
- News Arecor Therapeutics plc
- Arecor Therapeutics plc Announces Stepping Down of Susan Lowther as Company Secretary and as A Board Director, Effective from July 22,2024